<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Between 1981 and 1985, 27 patients with <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> have been treated by immunosuppression with antilymphocyte globulin and <z:chebi fb="2" ids="8378">prednisolone</z:chebi> or allogeneic bone marrow transplantation </plain></SENT>
<SENT sid="1" pm="."><plain>Fifteen have undergone bone marrow transplantation and have an actuarial survival at 54 months of 65% +/- 12% (95% confidence limits) </plain></SENT>
<SENT sid="2" pm="."><plain>There have been four <z:hpo ids='HP_0011420'>deaths</z:hpo> from graft rejection, <z:mpath ids='MPATH_681'>septicemia</z:mpath> (two), and <z:e sem="disease" ids="C0018133" disease_type="Disease or Syndrome" abbrv="GVH">graft-versus-host disease</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>Twelve have received antilymphocyte globulin and have an actuarial survival at 56 months of 67% +/- 21% </plain></SENT>
<SENT sid="4" pm="."><plain>Five of these now have a <z:mpath ids='MPATH_458'>normal</z:mpath> blood count and two have had good partial responses and are self supporting </plain></SENT>
<SENT sid="5" pm="."><plain>Of the five non-responders, three survived, two with persistent <z:mpath ids='MPATH_58'>aplasia</z:mpath> and one after allogeneic bone marrow transplantation </plain></SENT>
<SENT sid="6" pm="."><plain>Two are dead, one of <z:mp ids='MP_0001914'>hemorrhage</z:mp> and one after mismatched bone marrow transplantation </plain></SENT>
<SENT sid="7" pm="."><plain>In this study antilymphocyte globulin produced survival equivalent to bone marrow transplantation although only 58% of patients had a response to the antilymphocyte globulin </plain></SENT>
<SENT sid="8" pm="."><plain>The advantages and disadvantages of these two methods of treatment are discussed </plain></SENT>
</text></document>